Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11557501 | 0.98 | FDPS (0.47) | FDPSSMPD1GGPS1 | |
| SCHEMBL16005396 | 0.81 | FDPS (0.48) | FDPSSMPD1GGPS1 | |
| SCHEMBL16005421 | 0.81 | FDPS (0.48) | FDPSSMPD1GGPS1 | |
| Hydrochloric Acid SCHEMBL27847712 | 0.81 | FDPS (0.48) | FDPSSMPD1GGPS1 | |
| SCHEMBL16005051 | 0.81 | FDPS (0.48) | FDPSSMPD1GGPS1 | |
| Hydrochloric Acid SCHEMBL602452 | 0.78 | SMPD1 (0.43) | FDPSSMPD1GGPS1 | |
| Hydrochloric Acid SCHEMBL9485806 | 0.78 | FDPS (0.46) | FDPSSMPD1GGPS1 | |
| SCHEMBL6938402 | 0.78 | FDPS (0.50) | FDPSSMPD1GGPS1 | |
| SCHEMBL4286298 | 0.78 | FDPS (0.50) | FDPSSMPD1GGPS1 | |
| SCHEMBL4141311 | 0.78 | FDPS (0.50) | FDPSSMPD1GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3894015-B1 | SHAMPOO COMPOSITION COMPRISING SHEET-LIKE MICROCAPSULES | PROCTER & GAMBLE (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4103335-B1 | BOTTLE ADAPTED FOR STORING A LIQUID COMPOSITION WITH AN AESTHETIC DESIGN SUSPENDED THEREIN | PROCTER & GAMBLE (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3663384-B1 | PARTICULATE LAUNDRY SOFTENING WASH ADDITIVE | PROCTER & GAMBLE (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3727323-B1 | CLEAR SHAMPOO COMPOSITION CONTAINING SILICONE POLYMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4729046-A2 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS | The Procter & Gamble Company (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-4337333-B1 | SHAMPOO COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4171483-B1 | DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS | PROCTER & GAMBLE (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4349950-B1 | FABRIC CARE COMPOSITION | PROCTER & GAMBLE (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12576013-B2 | Dissolvable solid fibrous shampoo articles containing salts | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-17 | — | — | US | disclosed |
| EP-3784352-B1 | COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS | PROCTER & GAMBLE (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2006113658-A2 | DILUTE FABRIC CARE COMPOSITIONS COMPRISING THICKENERS AND FABRIC CARE COMPOSITIONS FOR USE IN THE PRESENCE OF ANIONIC CARRY-OVER | THE PROCTER & GAMBLE COMPANY (US) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006063092-A1 | FABRIC ENHANCING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-15 | — | — | WO | disclosed |
| US-20060122094-A1 | Fabric enhancing composition | PROCTER & GAMBLE COMPANY, THE | 2006-06-08 | — | — | US | disclosed |
| WO-2006044875-A1 | CONCENTRATED FABRIC SOFTENER ACTIVE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2006-04-27 | — | — | WO | disclosed |
| US-20060089293-A1 | Concentrated fabric softener active compositions | PROCTER & GAMBLE COMPANY, THE | 2006-04-27 | — | — | US | disclosed |
| WO-2006014416-A1 | PERSONAL CARE COMPOSITIONS CONTAINING CATIONICALLY MODIFIED STARCH AND AN ANIONIC SURFACTANT SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20060002880-A1 | Personal care compositions containing cationically modified starch and an anionic surfactant system | THE PROCTER & GAMBLE COMPANY | 2006-01-05 | — | — | US | disclosed |
| EP-1606373-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH | THE PROCTER & GAMBLE COMPANY (US) | 2005-12-21 | — | — | EP | disclosed |
| US-20040204337-A1 | Fabric care compositions comprising cationic starch | THE PROCTER & GAMBLE COMPANY | 2004-10-14 | — | — | US | disclosed |
| WO-2004087854-A1 | FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH | THE PROCTER & GAMBLE COMPANY (US) | 2004-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060002880-A1 | Personal care compositions containing cationically modified starch and an anionic surfactant system | CUTA, SGMS1, SGMS2 | FDPS 4813/4885SMPD1 644/4885GGPS1 4502/4885 |
| US-12576013-B2 | Dissolvable solid fibrous shampoo articles containing salts | SLC6A5, GLUL, SLC6A1 | FDPS 2506/4885SMPD1 2029/4885GGPS1 1104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.